Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage (RICH-2)
The Safety and Efficacy of Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage: A Multicenter, Randomized, Controlled Study
Sponsor: Capital Medical University
Listed as NCT04657133, this PHASE3 trial focuses on Acute Stroke and Intracerebral Hemorrhage and remains ongoing. Sponsored by Capital Medical University, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Recruiting → Unknown
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE3
-
Sep 2022 — Jul 2024 [monthly]
Recruiting PHASE3
-
Jun 2021 — Sep 2022 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Feb 2021 — Jun 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Capital Medical University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Beijing, China , Changzhou, China , Chengde, China , Hengshui, China , Jiaxing, China , Nanyang, China , Shaoxing, China , Tianjin, China , Tongliao, China , Xuzhou, China and 1 more location